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the patch. Patients were examined using trans-thoracic
echocardiography consecutively at discharge form the
hospital, and at 3–6 months and yearly after discharge.
The mean follow up time was 78 months. The early mor-
tality was 5.19% (17 patients), and there were no late mor-
tality. The highest mortality was reported during the
beginning of the pediatric surgical program. The mortal-
ity for the last 100 patients was 1%. The pressure gradient
across the pulmonary valve in 249 patients (87%, was less
than 20 mmHg. Mild pulmonary stenosis (pressure gradi-
ent of 20–40 mmHg) was present in 32 patients (11.14%)
and moderate pulmonary stenosis with gradient
40–60 mmHg was manifested in 4 patients (1.39%).
Reconstruction of the new Pulmonary artery during the
ASO, using the quadrangular autologous fresh pericar-
dial patch, is effective and reproducible in reducing the
incidence of post-operative pulmonary stenosis.
http://dx.doi:10.1016/j.jsha.2016.04.008
8. Are nurse-led prosthetic valve anticoagulation
clinics effective?
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Valvular heart disease is a major and serious health-
care issue. There is an increasing evidence that Nurse-
led anticoagulation clinics may improve patients’ man-
agement and care.This is a retrospective comparison
study that included the first 94 patients enrolled in the
Nurse Led Prosthetic Valve Anticoagulation Clinic
(PVATC) in King Abdul-Aziz Cardiac Centre between
April and June 2013, and received Warfarin by General
Cardiology Clinics for one year pre enrollment in
PVATC, and one year after. Time in Therapeutic Range
(TTR) of the International Normalized Ratio (INR) was
calculated and compared between pre and post PVATC
enrolment. Other data including demographics and
comorbidities were collected and analyzed. Mean age of
patients was 53  12.5 years and males were 56%. Atrial
fibrillation was found in 37%, Diabetes Mellitus in 28%
and Hypertension in 34%. Mean TTR was 72% pre enroll-
ment in PVATC as compared to 78.9% after (P < 0.006).
Median TTR was 75% pre, and 81.5% after attending
the PVATC (P < 0.0001). 56% of patients pre enrollment
had TTR values above 70% threshold, compared to 75%
after enrollment. Nurse-Led PVATC has significant
impact on the care provided to patients receiving anticoa-
gulation treatment.
http://dx.doi:10.1016/j.jsha.2016.04.009
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9. Incidence of tricuspid valve regurgitation
following pacemaker/defibrillator lead extraction
A. AlFagih a, A.W. Al-Johar b, A. Aljasser b,
H. AlOnazi a, A. Ahmed a, Y. Al Hebaishi a
aPrince Sultan Cardiac Center, Cardiology, Riyadh,
Saudi Arabia; bKing Saud University, College of
Medicine, Riyadh, Saudi Arabia
Despite advanced sterile techniques in cardiac device
implantations, long-term complications such as wound
infections and/or lead-induced endocarditis can develop
mandating lead and device extraction. It has been sug-
gested that lead extraction carries a risk of new-onset
Tricuspid Regurgitation (TR), or a deterioration of a for-
merly known regurgitant valve. Yet, there is no enough
scientific evidence to our knowledge to back this claim.
In this study we aim to explore the risk of TR following
lead extraction.We conducted a retrospective chart
review in 113 patients whom underwent lead extraction
at Prince Sultan Cardiac Center in Saudi Arabia during
the period of Jan, 2002 to Jul, 2015. Six patients under-
went lead extraction twice, making the total number of
extractions to be 119. Of this study cohort, we include
52 cases who had Tricuspid valve function evaluation
via Transthoracic Echocardiography (TTE) prior to and
after device and lead extraction. TR severity was
assessed using a grading system as the following; nor-
mal, mild, mild-to-moderate, moderate-to-severe, and
severe. Worsening or improvement by more than 1
grade was considered clinically significant. TR following
lead extraction was examined over a median of 5
months. Of the 52 cases included in this study, 37
(71.2%) were males and 15 (28.8%) were females, with
a mean age of 46 (SD = 18) years. Eleven patients
(21.2%) experienced worsening of TR (3 had normal
functioning valves before extraction, and 8 were known
to have TR prior to extraction), 2 (3.8%) had improve-
ment, and the majority (75.0%) did not experience any
significant changes. Compared with those who had no
change, average lead duration was higher in the wor-
sening TR group (67.2 vs. 27.9 months). A lead-
attached vegetation was detected in 4 out of the 11
patients with TR. Lead type (High-voltage vs. Pacing)
was not predictive of TR, 5 (45.5%) of the patients in
the worsening group had high-voltage leads, while the
remaining (54.5%) had pacing leads across the valve.
Our study being a simple descriptive study could not
find overwhelming evidence to support the claim that
there is an elevated risk of new onset TR or deteriora-
tion of a regurgitant valve following pacemaker/defibril-
lator lead extraction. However, our study being a simple
observational study with a considerably small sample
size may influence the findings. Lack of appropriate
control group in this study is a limitation in appraising
the hypothesis. As there is scarcity of data in this impor-
tant area of cardiac research, our findings should
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prompt motivation for larger and well controlled cohort
studies.
http://dx.doi:10.1016/j.jsha.2016.04.010
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tion on pulmonary artery systolic pressure
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As the number of cardiac device implantations are on
a rise, there is a parallel increase in their long-term com-
plications including device-related infection that will
require lead extraction. As the detachment of fibrosed
debris reaching the pulmonary trunk can occur during
the extraction, the risk of developing new-onset Pulmon-
ary Hypertension (P. HTN) increases with every extrac-
tion. Yet, there is paucity of evidence to support such
claim. Given the clinical significance of such findings,
we sought to determine the risk. A chart review of 113
patients whom underwent lead extraction at Prince Sul-
tan Cardiac Center in Saudi Arabia during the period
of Jan, 2002 to Jul, 2015 was carried out. Six patients
had lead extraction twice, making the total number of
extractions to be 119. Of this study cohort, only 45 cases
had Pulmonary Artery Systolic Pressure (PASP) mea-
surement via Transthoracic Echocardiography (TTE)
prior to and after device extraction. PASP measurements
were obtained as reported whether a single measure-
ment or a range between two readings, and an average
was calculated in case of two readings. A difference of
10 mmHg or more in the PASP, whether progression or
improvement, was considered clinically significant.Med-
ian follow up of TTE after lead and device extraction
was 5 months. Out of 45 patients, 31 (68.9%) were males
and 14 (31.1%) were females. Average age was 46.5
(SD = 17) years. Eleven patients (24.4%) experienced a
significant increase of PASP after lead extraction (10
had normal pressure readings before extraction, and only
one had progression to a more severe form of the dis-
ease), 9 patients (20.0%) showed improvement, and the
remaining (55.6%) did not show any significant change
in PASP. Average implantation-to-extraction duration of
the leads was higher among those who had no pressure
difference (50.6 vs. 23.3 months). When looking through
potential predictors that may increase the likelihood of
developing P. HTN, there was no association with a
pre-existing lead-attached vegetation (2 patients only),
nor the type of lead (6 high-voltage vs. 5 pacing leads
across the tricuspid valve). In patients who developed
P. HTN, 8 (72.7%) had their devices extracted as a result
of a complicated infection (wound infections and/or
infective endocarditis), as opposed to 3 (27.3%) whom
underwent device extraction for other indications. Our
simple descriptive study showed that the risk of develop-
ing P. HTN following lead and device extraction is negli-
gible. However, our findings should be interpreted in the
light of the limitations such as a small sample size and
lack of comparable control group. Paucity of data and evi-
dence on the long-term complications subsequent to
device and lead extractions will be a subject of further
exploration given the potential connection to patient out-
comes and management.
http://dx.doi:10.1016/j.jsha.2016.04.011
11. Prevalence of psychiatric symptoms among
patients with recurrent vasovagal and unexplained
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AlHadi c,d, A. Hersi b
aKing Saud University, College of Medicine, Riyadh,
Saudi Arabia; bKing Saud University, Department
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cKing Saud University, Department of Psychiatry,
College of Medicine, Riyadh, Saudi Arabia; dSABIC
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Syncope is defined as a transient loss of consciousness
and absence of postural tone followed by spontaneous
recovery. Neurally mediated syncope (vasovagal) and
idiopathic unexplained syncope (US) are the most com-
mon causes of syncope. Syncope is a very limiting disease
that, if recurrent, affects the patients’ physical and psycho-
logical health. Our objective from this study is to measure
the prevalence of psychiatric symptoms among patients
with US. All patients (>12 years) with vasovagal or US
who were evaluated in King Khalid University Hospital
were identified. Echocardiography and table tilt test
reports were reviewed and patients who had cardiac syn-
cope (due to arrhythmia or structural heart disease) were
excluded (N = 18). Ninety-four patients were included for
further psychiatric assessment. The patients were con-
tacted to fill the Symptoms Checklist-90-Revised (SCL-
90-R), which is a self-reporting questionnaire used to eval-
uate traits of depression, anxiety, somatization disorder
and phobia. SCL-90-R scale has been translated to Arabic
and validated in previous studies. Of the included cohort,
43 responded to fill the assessment scale, and 51 were
excluded due to failure of communication (N = 41) or refu-
sal to participate (N = 10). A control group was recruited
with a case: control ratio of 1:3 matching for age, gender,
and chronic illnesses.There were 43 patients and 129 con-
trol subjects, with predominance of females (67.4%) and an
average age of 33.8 (SD = 16). There was no difference in
average scores of depression (13 vs. 14.53, P = 0.31), anxiety
(11.3 vs. 10.4, P = 0.51), or phobia (5.4 vs. 5.2, P = 0.88). How-
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